Baird Extends HealthEquity (HQY) Residency on Fresh Pick List
Tweet
Share
E-mailGet Alerts HQY Hot Sheet
Rating Summary:
21 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Baird Extends HealthEquity (NASDAQ: HQY) Residency on Fresh Pick List.
Analyst Mark Marcon comments "We are extending our Bullish Fresh Pick on HealthEquity (HQY) following thisweek's FOMC meeting which indicated a Fed funds rate of 5.1% in 2023 followed by4.1% in 2024. We are extending our Bullish Fresh Pick through March 24 which isright after HQY posts FQ4 results which we believe will be positive. HQY is leveredto higher rates which will benefit earnings over the next few years (particularly ifrates remain elevated). HQY could further benefit as PMs seek some diversification/positive exposure to higher rates."
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsRelated Entities
Robert W Baird, Federal Open Market Committee, Earnings, Fresh Pick ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
